Log In | Register
Boehringer Ingelheim, a German drug manufacturer is getting ready to market the female equivalent of Viagra for premenopausal women distressed by low sexual desire, even as it prepares for the US Food and Drug Administration's (FDA) drug approval hearing Friday.
Since, Viagra was launched in 1998, pharmaceutical companies have been searching for a female version of the drug, and many believe flibanserin is the answer for women who believe they have been left behind.
It was during the testing of flibanserin as an anti-depressant that Boehringer Ingelheim discovered its possibilities from some of the desirable side effects it yielded, such as, making sex more pleasurable for women, including increasing their libido.
